Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 2/2013

01-04-2013 | Research Article

Evaluation of adherence to international guidelines for treating patients with type 2 diabetes mellitus in Kuwait

Authors: Dalal M. Al-Taweel, Abdelmoneim I. Awad, B. Julienne Johnson

Published in: International Journal of Clinical Pharmacy | Issue 2/2013

Login to get access

Abstract

Background Clinical guidelines derived from scientific evidence provide the basis of consistent standardized prescribing. Despite an alarming increase of diabetes in Kuwait, no studies related to the quality of prescribing in diabetes were found. Before pharmaceutical care can be implemented to improve the quality of care of patients with diabetes, it is important to determine whether prescribers are compliant with comprehensive international guidelines for cardioprevention and glycaemic control. Objective To evaluate the adherence to clinical guidelines for treating patients with type 2 diabetes mellitus in primary care centres and secondary care centres (hospitals) using a developed and validated medication assessment tool with reference to international guidelines. Setting Outpatient diabetes clinics in 8 primary care centres and 4 secondary care centres across four healthcare regions in Kuwait. Method A quantitative, cross-sectional study involving a sample of 652 Kuwaiti patients with type 2 diabetes, who were selected using systematic sampling from the study settings. Data were collected retrospectively from the patients’ medical records using a validated 43-criterion medication assessment tool (MATKW) designed to assess cardioprevention and treatment in patients with type 2 diabetes. Descriptive and comparative analysis was conducted using SPSS version 17. Main Outcome Measure Frequency of prescribing adherence to agreed definitions of criteria derived from international guidelines. Results Overall adherence to prescribing diabetes guidelines was 77.7 % (95 % CI 76.7–78.6 %). Significantly higher prescribing adherence was found in the secondary care facilities, 82.4 % (95 % CI 81.2–83.6 %) compared to primary care 72.5 % (95 % CI 71.0–73.9 %) (p < 0.001). Nineteen criteria out of 43 achieved an adherence >80 % in secondary care compared to ten criteria in primary care. The documentation of patients’ records was found to be inconsistent at the study healthcare facilities. Nonoptimal achievement of target goals for HbA1c, blood pressure and BMI was prevalent among the study population. Conclusion: A tool such as MATKW highlights areas for review and possible improvement in prescribing adherence. Our findings reveal problem areas in prescribing practices and documentation of patients’ records. Cost-effective multifaceted interventions are needed to improve current prescribing practices and documentation.
Literature
2.
go back to reference American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2009;32:S13–61.CrossRef American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2009;32:S13–61.CrossRef
4.
go back to reference Abdella N, Khogali M, Al-Ali S, Gumaa K, Bajaj J. Known Type 2 diabetes mellitus among the Kuwaiti population: a prevalence study. Acta Diabetol. 1996;33:145–9.PubMedCrossRef Abdella N, Khogali M, Al-Ali S, Gumaa K, Bajaj J. Known Type 2 diabetes mellitus among the Kuwaiti population: a prevalence study. Acta Diabetol. 1996;33:145–9.PubMedCrossRef
5.
go back to reference Advisory Commission on Health Consumer Protection and Quality in the Health Care Industry. Quality First: Better Health Care for All Americans. Washington: U.S. Government Printing Office; 1998. Advisory Commission on Health Consumer Protection and Quality in the Health Care Industry. Quality First: Better Health Care for All Americans. Washington: U.S. Government Printing Office; 1998.
6.
go back to reference Al-Adsani A, Al-Faraj J, Al-Sultan F, El-Feky M, Al-Mezel N, Saba W, Aljassar S. Evaluation of the impact of the Kuwait Diabetes Care Program on the quality of diabetes care. Med Princ Pract. 2008;17:14–9.PubMedCrossRef Al-Adsani A, Al-Faraj J, Al-Sultan F, El-Feky M, Al-Mezel N, Saba W, Aljassar S. Evaluation of the impact of the Kuwait Diabetes Care Program on the quality of diabetes care. Med Princ Pract. 2008;17:14–9.PubMedCrossRef
7.
go back to reference Hakonsen GD, Hudson S, Loennechen T. Design and validation of a medication assessment tool for cancer pain management. Pharm World Sci. 2006;28:342–51.PubMedCrossRef Hakonsen GD, Hudson S, Loennechen T. Design and validation of a medication assessment tool for cancer pain management. Pharm World Sci. 2006;28:342–51.PubMedCrossRef
8.
go back to reference Hakonsen GD, Torbergsen AL, Strelec P, Cambell D, Hudson S, Loennechen T. A medication assessment tool to evaluate adherence to medication guideline criteria in cancer pain management. Int J Pharm Pract. 2008;16:99–107.CrossRef Hakonsen GD, Torbergsen AL, Strelec P, Cambell D, Hudson S, Loennechen T. A medication assessment tool to evaluate adherence to medication guideline criteria in cancer pain management. Int J Pharm Pract. 2008;16:99–107.CrossRef
9.
go back to reference Kamyar M, Johnson BJ, McAnaw J, Lemmens-Gruber R, Hudson S. Adherence to clinical guidelines in the prevention of coronary heart disease in type II diabetes mellitus. Pharm World Sci. 2008;30:120–7.PubMedCrossRef Kamyar M, Johnson BJ, McAnaw J, Lemmens-Gruber R, Hudson S. Adherence to clinical guidelines in the prevention of coronary heart disease in type II diabetes mellitus. Pharm World Sci. 2008;30:120–7.PubMedCrossRef
11.
go back to reference Guidelines on diabetes, pre-diabetes and cardiovascular diseases: The Task Force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007;9 (suppl C): C3–C74. doi: 10.1093/eurheartj/ehl261. Guidelines on diabetes, pre-diabetes and cardiovascular diseases: The Task Force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007;9 (suppl C): C3–C74. doi: 10.​1093/​eurheartj/​ehl261.
14.
go back to reference Diab M, Towle I, Johnson BJ, Hudson S. The quality of medication use in obesity management and in primary prevention of cardiovascular disease (CVD). Pharm World Sci. 2010;32:241. Diab M, Towle I, Johnson BJ, Hudson S. The quality of medication use in obesity management and in primary prevention of cardiovascular disease (CVD). Pharm World Sci. 2010;32:241.
15.
go back to reference Khunti K, Ganguli S. Who looks after people with diabetes: primary or secondary care? J R Soc Med. 2000;93:183–6.PubMed Khunti K, Ganguli S. Who looks after people with diabetes: primary or secondary care? J R Soc Med. 2000;93:183–6.PubMed
16.
go back to reference Miller R, Sim I. Physician’s use of electronic medical records: barriers and solutions. Health Aff. 2004;23:116–26.CrossRef Miller R, Sim I. Physician’s use of electronic medical records: barriers and solutions. Health Aff. 2004;23:116–26.CrossRef
17.
go back to reference Laing RO, Hogerzeil HV, Ross-Degnan D. Ten recommendations to improve use of medicines in developing countries. Health Policy Plan. 2001;16:13–20.PubMedCrossRef Laing RO, Hogerzeil HV, Ross-Degnan D. Ten recommendations to improve use of medicines in developing countries. Health Policy Plan. 2001;16:13–20.PubMedCrossRef
18.
go back to reference Bero LA, Grilli R, Grimshaw JM, Harvey E, Oxman AD, Thomson MA. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group. BMJ. 1998;317:465–8.PubMedCrossRef Bero LA, Grilli R, Grimshaw JM, Harvey E, Oxman AD, Thomson MA. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group. BMJ. 1998;317:465–8.PubMedCrossRef
19.
go back to reference Pringle M, Stewart-Evans C, Coupland C, Williams I, Allison S, Sterland J. Influences on control in diabetes mellitus: patient, doctor, practice or delivery of care? BMJ. 1993;306:630–4.PubMedCrossRef Pringle M, Stewart-Evans C, Coupland C, Williams I, Allison S, Sterland J. Influences on control in diabetes mellitus: patient, doctor, practice or delivery of care? BMJ. 1993;306:630–4.PubMedCrossRef
20.
go back to reference Whitley HP, Fermo JD, Ragucci K, Chumney EC. Assessment of patient knowledge of diabetic goals, self-reported medication adherence, and goal attainment. Pharm Pract. 2006;4:183–90. Whitley HP, Fermo JD, Ragucci K, Chumney EC. Assessment of patient knowledge of diabetic goals, self-reported medication adherence, and goal attainment. Pharm Pract. 2006;4:183–90.
21.
go back to reference Clifford RM, Davis WA, Batty KT, Davis TM. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care. 2005;28:771–6.PubMedCrossRef Clifford RM, Davis WA, Batty KT, Davis TM. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care. 2005;28:771–6.PubMedCrossRef
22.
go back to reference Odegard PS, Goo A, Hummel J, Williams KL, Gray SL. Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Ann Pharmacother. 2005;39:433–40.PubMedCrossRef Odegard PS, Goo A, Hummel J, Williams KL, Gray SL. Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Ann Pharmacother. 2005;39:433–40.PubMedCrossRef
23.
go back to reference Kiel PJ, McCord AD. Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice. Ann Pharmacother. 2005;39:1828–32.PubMedCrossRef Kiel PJ, McCord AD. Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice. Ann Pharmacother. 2005;39:1828–32.PubMedCrossRef
Metadata
Title
Evaluation of adherence to international guidelines for treating patients with type 2 diabetes mellitus in Kuwait
Authors
Dalal M. Al-Taweel
Abdelmoneim I. Awad
B. Julienne Johnson
Publication date
01-04-2013
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 2/2013
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-012-9738-8

Other articles of this Issue 2/2013

International Journal of Clinical Pharmacy 2/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.